This post was co-authored by Michelle May, MD. In 2024, one in eight people reported taking a GLP-1 receptor agonist (or GLP-1 for short). GLP-1s signal the hypothalamus to reduce hunger signals and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results